Document is current
Any future updates will be listed below
-
Authors
Lund, Ken https://orcid.org/0000-0002-3959-2926
Larsen, Michael Due https://orcid.org/0000-0002-0623-2481
Knudsen, Torben https://orcid.org/0000-0003-0726-0115
Kjeldsen, Jens https://orcid.org/0000-0001-8148-6572
Nielsen, Rasmus Gaardskær
Brage, Søren https://orcid.org/0000-0002-1265-7355
Nørgård, Bente Mertz https://orcid.org/0000-0002-9514-3033
-
Funding
Funding for this research was provided by:
The Region of Southern Denmark
The University of Southern Denmark
The Beckett Foundation
The Odense University Hospital Chief Physician Foundation
UK medical research council ([MC_UU_00006/4])
The NIHR Biomedical Research Centre in Cambridge ([IS-BRC-1215-20014])
- License Information
-
More Information
Article History
Received: 4 October 2021
Accepted: 25 May 2022
First Online: 7 June 2022
Declarations
:
: This study was approved by the Danish Data Protection Agency [J.No. 2017-17-8498]. We used written consent from all patients and their legal parents. The Regional Ethics Committee of Southern Denmark [J.No.S-2017-0007] found that the study did not require ethical approval by law. All methods in the study were performed in accordance with the relevant guidelines, regulations and complies with the Declarations of Helsinki and The Act on Processing of Personal Data.
: Not applicable.
: Ken Lund has received a fellowship grant from Pfizer not related to this study. Jens Kjeldsen has received lecture fees from Tillotts and Ferring. Torben Knudsen has received lecture fees from Pfizer and Takeda. Torben Knudsen is an advisory board member at Tillotts, Janssen Pharma, and Takeda. The remaining authors have no conflicts of interest or disclosures.
